;

Datasets in detail TEST

Datasets are described in detail in the table below

You can find similar information via our entries at the HDR UK Innovation Gateway, in our Gut Reaction Collection.

Dataset

Source

          Abstract

Participant number

Availability

Release schedule

Links

Health & Lifestyle Questionnaire

Most NIHR BioResource participants complete a self-report form on recruitment. Typically this contains e.g. height, weight, smoking history and alcohol consumption, but also includes questions relating to disease history and current medications

23,002

Available now

Quarterly

Clinical report

Each participant recruited has an IBD-specific CRF completed by their clinical care team. These are non-exhaustive – we have the chance to ask for more information – but form the basis of analysis and recall.

34,189

Available now

Quarterly

Demographics

The NIHR BioResource acquires broad demographics from participants at recruitment. This is used to pre-screen or match participants when inviting them to take part in experimental medicine studies.

34,708

Available now

Quarterly

SNP chip data

In order to recall by genotype, participants have their DNA tested using one of the SNP chip arrays from eg. Illumina and Affymetrix (now Thermosfisher). The current iteration is the UK Biobank v2.1 from Thermofisher, which measures ~820k markers.

12,390

Available now – additional batches to follow up to ~ 31,000

Quarterly

SNP imputation data

SNP chip data can be used to impute many of the (non-rare) SNPs not included on the chips. The NIHR BioResource is using a modified version of the UK Biobank protocol to improve the options for recall.

12,390

Available now – additional batches to follow up to ~ 31,000

Quarterly

NHS Trust data

10 NHS Trusts have been asked to provide detailed data on participants in their Trust. Categories of data requested include: test results; prescribing; imaging; digital pathology; data from disease-specific databases and registries; discharge summaries.

4,902

Under curation

Available from October 2021

IBD Registry

The IBD Registry has the promise to bring Patient Reported Outcome Measures (PROMs) to the IBD Hub. However, these ~58k participants are currently provided de-identified by NHS Digital, and therefore a change in consent model is required to allow linkage.

N/A

Under ethical review

Available from October 2021

Whole genome/ exome sequencing

There is a substantial overlap between the IBD NIHR BioResource and the IBD UK Genetics Consortium (IBDGC). The NIHR BioResource provides some DNA samples. IBDGC data is being provided by the Wellcome Sanger Institute, who are performing the sequencing.

11,960 WES

2,231 WGS

Available now – additional batches of WES data to follow up to ~31k

Quarterly

Consent

The NIHR BioResource records consent dates and versions for each and every participant consent event. We also record use of opt-ins and opt-outs including pre-GDPR. This permits us to manage data releases in line with participants’ expectations.  

33,805

Applied to other releases

Applied to other releases

Contact details

NIHR BioResource

The NIHR BioResource acquires contact details – name, address, email address, phone/mobile number – from participants at recruitment. This is used to recontact participants to invite them to take part in experimental medicine studies.

33,794

Not available for research purposes

Not available for research purposes

Sample holding

NIHR BioResource samples are held at the NIHR National Biosample Centre in Milton Keynes. Metadata on what is available should become available through the UK CRC Tissue Directory, as mandated by Research Tissue Bank status.

21,442 DNA (more to be extracted)

29,310 plasma

32,280 serum

Available now

Quarterly

IBD Registry COVID-19

A consented IBD dataset of 9,800 participants, with a further 30,000 ethically-permissioned records for research related to COVID-19 and IBD. Includes patient demographics, medications plus vaccinations, responses and care received April 2020-June 2021.

Available now (linkable to Gut Reaction Datasets for COVID only studies)

Data collection complete

IBD Registry Main dataset

The IBD Registry captures longitudinal clinical data on IBD patients from NHS Trusts. The dataset includes demographics; diagnosis and phenotype; medications (greater details on biologics); interventions; clinical assessment and PROMS.

Available*,†

Data collection continuous

*for retrospective studies (service evaluation and quality of care), and for research with prospective recruitment of consented patients for data already held.

†Not currently linkable to other Gut Reaction Datasets but linkable to other datasets available through NHS Digital.